{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:09:25Z","timestamp":1784232565807,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117016","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:37:28Z","timestamp":1781840248000},"page":"117016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Upregulation of CDO1 by theaflavin-3,3\u2032-gallate induces apoptosis and inhibits cell proliferation in TNBC"],"prefix":"10.1016","volume":"185","author":[{"given":"Wenmei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luobin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117016_bb0005","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"8","key":"10.1016\/j.intimp.2026.117016_bb0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.117016_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13644","article-title":"Targeting novel regulated cell death: ferroptosis, pyroptosis and necroptosis in anti-pd-1\/pd-l1 cancer immunotherapy","volume":"57","author":"Yu","year":"2024","journal-title":"Cell Prolif."},{"issue":"6","key":"10.1016\/j.intimp.2026.117016_bb0020","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1021\/acs.jafc.1c07382","article-title":"Enhancing intestinal permeability of theaflavin-3,3\u2032-digallate by chitosan-caseinophosphopeptides nanocomplexes","volume":"70","author":"Jiang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.117016_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jff.2018.09.021","article-title":"Theaflavin-3,3\u2032-digallate inhibits ovarian cancer stem cells via suppressing wnt\/\u03b2-catenin signaling pathway","volume":"50","author":"Pan","year":"2018","journal-title":"J. Funct. Foods"},{"issue":"6","key":"10.1016\/j.intimp.2026.117016_bb0030","first-page":"1066","article-title":"Investigation of the azorean Camellia sinensis processing conditions to maximize the theaflavin 3,3\u2032-di-o-gallate content as a potential antiviral compound","volume":"11","author":"Paiva","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117016_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tiv.2007.11.021","article-title":"Theaflavin-3,3\u2032-digallate, a component of black tea: an inducer of oxidative stress and apoptosis","volume":"22","author":"Schuck","year":"2008","journal-title":"Toxicol. In Vitro: Int. J. Publ. Assoc. Bibra"},{"issue":"4","key":"10.1016\/j.intimp.2026.117016_bb0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-2952(99)00335-4","article-title":"Suppression of lipopolysaccharide-induced nuclear factor-kappab activity by theaflavin-3,3\u2032-digallate from black tea and other polyphenols through down-regulation of ikappab kinase activity in macrophages","volume":"59","author":"Pan","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2026.117016_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijbiomac.2016.10.072","article-title":"Effective synthesis of theaflavin-3,3\u2032-digallate with epigallocatechin-3-o-gallate and epicatechin gallate as substrates by using immobilized pear polyphenol oxidase","volume":"94","author":"Lei","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117016_bb0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1631\/jzus.B1100041","article-title":"Evaluation of the antioxidant effects of four main theaflavin derivatives through chemiluminescence and dna damage analyses","volume":"12","author":"Wu","year":"2011","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"22","key":"10.1016\/j.intimp.2026.117016_bb0055","first-page":"6465","article-title":"Differential effects of theaflavin monogallates on cell growth, apoptosis, and cox-2 gene expression in cancerous versus normal cells","volume":"60","author":"Lu","year":"2000","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117016_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.14712\/fb2007053050164","article-title":"Modulation of the oxidative stress and nuclear factor kappab activation by theaflavin 3,3\u2032-gallate in the rats exposed to cerebral ischemia-reperfusion","volume":"53","author":"Cai","year":"2007","journal-title":"Folia Biol (Praha)"},{"issue":"6","key":"10.1016\/j.intimp.2026.117016_bb0065","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3892\/ijo.2016.3472","article-title":"Theaflavin-3,3\u2032-digallate induces apoptosis and g2 cell cycle arrest through the akt\/mdm2\/p53 pathway in cisplatin-resistant ovarian cancer a2780\/cp70 cells","volume":"48","author":"Tu","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117016_bb0070","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","article-title":"Pd-l1-mediated gasdermin c expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis","volume":"22","author":"Hou","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117016_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11120731","article-title":"The cytotoxicity effect of resveratrol: cell cycle arrest and induced apoptosis of breast cancer 4t1 cells","volume":"11","author":"Wu","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"7","key":"10.1016\/j.intimp.2026.117016_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117016_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8966368","article-title":"Theaflavin-3,3\u2032-digallate plays a ros-mediated dual role in ferroptosis and apoptosis via the mapk pathway in human osteosarcoma cell lines and xenografts","volume":"2022","author":"He","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"issue":"9","key":"10.1016\/j.intimp.2026.117016_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1423","article-title":"Targeted demethylation of the cdo1 promoter based on crispr system inhibits the malignant potential of breast cancer cells","volume":"13","author":"Yang","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117016_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211108","article-title":"Clinical significance of cancer specific methylation of the cdo1 gene in small bowel cancer","volume":"14","author":"Kojima","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2026.117016_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1290330","article-title":"Epigenetic targeting of autophagy for cancer: dna and rna methylation","volume":"13","author":"Lin","year":"2023","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117016_bb0105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/15592294.2016.1241931","article-title":"Cdo1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients","volume":"11","author":"Meller","year":"2016","journal-title":"Epigenetics"},{"issue":"15","key":"10.1016\/j.intimp.2026.117016_bb0110","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/1078-0432.CCR-14-2049","article-title":"Promoter methylation of cdo1 identifies clear-cell renal cell cancer patients with poor survival outcome","volume":"21","author":"Deckers","year":"2015","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117016_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115299","article-title":"Dnai-peptide nanohybrid smart particles target bcl-2 oncogene and induce apoptosis in breast cancer cells","volume":"166","author":"Alipour","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2026.117016_bb0120","first-page":"123","article-title":"Quercetin induces apoptosis and necroptosis in mcf-7 breast cancer cells","volume":"118","author":"Khorsandi","year":"2017","journal-title":"Bratisl. Lek. Listy"},{"issue":"4","key":"10.1016\/j.intimp.2026.117016_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cyto.10091","article-title":"Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis","volume":"50","author":"Schiller","year":"2002","journal-title":"Cytometry"},{"issue":"6","key":"10.1016\/j.intimp.2026.117016_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12518","article-title":"Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the ampk-ulk1 axis","volume":"51","author":"Cao","year":"2018","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.intimp.2026.117016_bb0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF01366949","article-title":"Overexpression of bax enhances the radiation sensitivity in human breast cancer cells","volume":"27","author":"Sakakura","year":"1997","journal-title":"Surg. Today"},{"key":"10.1016\/j.intimp.2026.117016_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3047425","article-title":"Theaflavin-3,3\u2032-digallate protects cartilage from degradation by modulating inflammation and antioxidant pathways","volume":"2022","author":"Teng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2026.117016_bb0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2016.11.027","article-title":"In vitro and in vivo anti-inflammatory effects of theaflavin-3,3\u2032-digallate on lipopolysaccharide-induced inflammation","volume":"794","author":"Wu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117016_bb0150","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.10933","article-title":"Theaflavin-3,3\u2032-digallate attenuates cigarette smoke extract-induced pulmonary emphysema in mice by suppressing necroptosis","volume":"23","author":"Luan","year":"2022","journal-title":"Exp. Ther. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:38:59Z","timestamp":1784230739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S1567576926008623"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of CDO1 by theaflavin-3,3\u2032-gallate induces apoptosis and inhibits cell proliferation in TNBC","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117016"}}